DOI: 10.1055/s-00035024

Thrombosis and Haemostasis

Issue 02 · Volume 57 · 1987 DOI: 10.1055/s-008-39933

Original Article

  • 131
    Bröcker-Vriends, A H J T; Briët, E; Quadt, R; Dreesen, J C F M; Bakker, E; Claassen-Tegelaar, R; Kanhai, H H H; van de Kamp, J J P; Pearson, P L:

    Genotype Assignment of Haemophilia A by Use of Intragenic and Extragenic Restriction Fragment Length Polymorphisms

  • 137
    Gram, Jørgen; Jespersen, Jørgen:

    A Selective Depression of Tissue Plasminogen Activator (t-PA) Activity in Euglobulins Characterises a Risk Group Among Survivors of Acute Myocardial Infarction

  • 140
    de Jong, Egbert; Knot, Eduard A R; Piket, Dick; Iburg, Alfred H C; Rijken, Dick C; Veenhof, Kees H N; Dooijewaard, Gerard; ten Cate, Jan W:

    Increased Plasminogen Activator Inhibition Levels in Malignancy

  • 144
    Rosner, Esther; Pauzner, Rachel; Lusky, Ayala; Modan, Michaela; Many, Amira:

    Detection and Quantitative Evaluation of Lupus Circulating Anticoagulant Activity

  • 148
    Van Hinsbergh, Victor W M; Sprengers, Erik D; Kooistra, Teake:

    Effect of Thrombin on the Production of Plasminogen Activators and PA Inhibitor-1 by Human Foreskin Microvascular Endothelial Cells

  • 154
    de Moerloose, P A; Reber, G; Vernet, Ph; Minazio, Ph; Bouvier, C A:

    Antithrombin III Geneva: A Hereditary Abnormal AT III with Defective Heparin Cofactor Activity

  • 158
    Ushikubi, Fumitaka; Okuma, Minoru; Kanaji, Kenji; Sugiyama, Tateo; Ogorochi, Toshiya; Narumiya, Shuh; Uchino, Haruto:

    Hemorrhagic Thrombocytopathy with Platelet Thromboxane A2 Receptor Abnormality: Defective Signal Transduction with Normal Binding Activity

  • 165
    Hara, H; Tamao, Y; Kikumoto, R; Okamoto, S:

    Effect of a Synthetic Thrombin Inhibitor MCI-9038 on Experimental Models of Disseminated Intravascular Coagulation in Rabbits

  • 171
    Jansen, J W C M; Haverkate, F; Koopman, J; Nieuwenhuis, H K; Kluft, C; Boschman, Th A C:

    Influence of Factor Xllla Activity on Human Whole Blood Clot Lysis In Vitro

  • 176
    de Fouw, N J; van Hinsbergh, V W M; de Jong, Y F; Haverkate, F; Bertina, R M:

    The Interaction of Activated Protein C and Thrombin with the Plasminogen Activator Inhibitor Released from Human Endothelial Cells

  • 183
    Sala, N; Borrell, M; Bauer, K A; Viganò-D’Angelo, S; Fontcuberta, J; Félez, J; Rutllant, M L:

    Dysfunctional Activated Protein C (PC Cádiz) in a Patient with Thrombotic Disease

  • 187
    Handley, Dean A; Van Valen, Ronald G; Winslow, Christine M; Tomesch, John C; Saunders, Robert N:

    In Vitro and In Vivo Pharmacological Profiles of the PAF Receptor Antagonist SRI 63-675

  • 191
    Joseph, Sunil; Krishnamurthi, Sushila; Kakkar, Vijay V:

    Effect of the Polyamine-Spermine on Agonist-Induced Human Platelet Activation - Specific Inhibition of "Aggregation-Independent" Events Induced by Thrombin, but not by Collagen, Thromboxane Mimetic, Phorbol Ester or Calcium lonophore

  • 196
    Bertina, R M; van der Linden, I K; Engesser, L; Muller, H P; Brommer, E J P:

    Hereditary Heparin Cofactor II Deficiency and the Risk of Development of Thrombosis

  • 201
    Scarabin, P Y; Strain, L; Ludlam, C A; Jones, J; Kohner, E M:

    Reliability of a Single β-Thromboglobulin Measurement in a Diabetic Population : Importance of PGE1 in Anticoagulant Mixture

  • 205
    Petersen, Lars Christian; Handest, Peter; Brender, Jytte; Selmer, Johan; Jørgensen, Maja; Thorsen, Sixtus:

    A Sensitive Solid-Phase Immunosorbent Assay for Tissue-Type Plasminogen Activator Activity in Plasma Using Trinitrobenzoylated Poly-D-Lysine as a Stimulator for Plasminogen Activation

  • 212
    Thorsen, L I; Gaudernack, G; Brosstad, F; Pedersen, T M; Solum, N O:

    Identification of Platelet Antigens by Monoclonal Antibodies Using Crossed Immunoelectrophoresis with Immunoblotting of the Monoclonal Antibody

  • 217
    Enayat, M S; Hill, F G H; Robinson, W; Prowse, C V; Hornsey, V S:

    Evaluation of Monoclonal Antibodies to vWf Antigen for Use in Autoradiographing vWf Multimer Analysis

  • 222
    Soberay, A H; Herzberg, M C; Rudney, J D; Nieuwenhuis, H K; Sixma, J J; Seligsohn, U:

    Responses of Platelets to Strains of Streptococcus sanguis: Findings in Healthy Subjects, Bernard-Soulier, Glanzmann’s, and Collagen-Unresponsive Patients

  • 226
    van den Besselaar, A M H P; Meeuwisse-Braun, J; Jansen-Grüter, R; Bertina, R M:

    Monitoring Heparin Therapy by the Activated Partial Thromboplastin Time - The Effect of Pre-Analytical Conditions

    • Letters to the Editor

  • 232
    O’Brien, J R:

    Multiple Therapy for Multifactorial Thrombosis

  • 233
    Hoyle, Christine; Ludlam, C A:

    Acquired Factor VIII Inhibitor Associated with Multiple Sclerosis, Successfully Treated with Porcine Factor VIII

  • 234
    Forestier, François; Daffos, Fernand; Rainaut, Martine; Toulemonde, Francis:

    Low Molecular Weight Heparin (CY 216) Does Not Cross the Placenta During the Third Trimester of Pregnancy

  • 235
    Gresele, Paolo; Amout, Jef; Vermylen, Jos:

    Dipyridamole Inhibits Leukotriene B4 Synthesis

  • 236
    Williams, Eliot C:

    Cold-Induced In Vitro Precipitation of Factor V in a Patient with Monoclonal IgM Cryoglobulinemia

  • 238
    Finazzi, Guido; Cortelazzo, Sergio; Viero, Piera; Galli, Monica; Barbui, Tiziano:

    Maternal Lupus Anticoagulant and Fatal Neonatal Thrombosis

  • 239
    de Prost, D; Katlama, C; Pialoux, G; Karsenty-Mathonnet, F; Wolff, M:

    Heparin-Like Anticoagulant Associated with AIDS

  • 240
    Schwarz, H P; Schernthaner, G; Griffin, J H:

    Decreased Plasma Levels of Protein S in Well-Controlled Type I Diabetes Mellitus

  • 241
    Harenberg, J; Augustin, J:

    Antithrombotic Action of Hepatic Triglyceride Lipase - Fact or Fictaon

  • 242
    Barrowcliffe, Trevor W:

    Antithrombotic Action of Hepatic Triglyceride Lipase - Fact or Fiction -Rejoinder